News & Updates

Show Multimedia Only

SAVE-MORE subgroup analysis further reinforces anakinra benefit in COVID-19

27 Jan 2023 by

The benefit of anakinra treatment in patients hospitalized with COVID-19 is consistent regardless of age, sex, comorbidities, and suPAR* levels, according to subgroup analysis of the SAVE-MORE trial.

SAVE-MORE subgroup analysis further reinforces anakinra benefit in COVID-19

27 Jan 2023

Proton therapy reirradiation confers survival benefits in head and neck cancer, with caveat

27 Jan 2023

Treatment with proton therapy reirradiation for head and neck cancer appears to improve survival outcomes in patients, but this benefit comes with substantial toxic effects, according to a study.

Proton therapy reirradiation confers survival benefits in head and neck cancer, with caveat

27 Jan 2023

Oral ritlecitinib safe, effective for treatment of active nonsegmental vitiligo

27 Jan 2023

Treatment with oral ritlecitinib improves outcomes in patients with active nonsegmental vitiligo, without any serious adverse events over 48 weeks, results of a study have shown.

Oral ritlecitinib safe, effective for treatment of active nonsegmental vitiligo

27 Jan 2023

Add-on cannabidiol induces sustained seizure reduction in treatment-resistant epilepsy

27 Jan 2023

Patients with treatment-resistant epilepsy appear to benefit from add-on cannabidiol, which a recent study has shown to help reduce seizure frequency for up to 192 weeks.

Add-on cannabidiol induces sustained seizure reduction in treatment-resistant epilepsy

27 Jan 2023

SGLT2 inhibitors cut obstructive airway disease risk in type 2 diabetes

26 Jan 2023 by

Treatment with sodium-glucose cotransporter 2 (SGLT2) inhibitors appears to have the added benefit of reducing the incidence of obstructive airway disease (OAD) in Asian patients with type 2 diabetes (T2D), as shown in a study from Hong Kong.

SGLT2 inhibitors cut obstructive airway disease risk in type 2 diabetes

26 Jan 2023

Durable benefits with beti-cel therapy in beta-thalassaemia

26 Jan 2023 by

One-time ex-vivo gene therapy with betibeglogene autotemcel (beti-cel) reduces the need for transfusion in patients with transfusion-dependent beta-thalassaemia in an analysis of studies presented at ASH 2022.

Durable benefits with beti-cel therapy in beta-thalassaemia

26 Jan 2023

$Low BMD, fracture risk upped in childhood cancer survivors$

Low BMD, fracture risk upped in childhood cancer survivors

25 Jan 2023 by

Childhood cancer survivors (CCS) appear to have an increased risk of low bone mineral density (BMD) and fracture compared with the general population, according to a cross-sectional study from the Netherlands.

Low BMD, fracture risk upped in childhood cancer survivors

25 Jan 2023

Immune checkpoint inhibitors carry some risk of hepatotoxicity

25 Jan 2023

The use of immune checkpoint inhibitors (ICIs) for the treatment of various cancers appears to have hepatotoxic effects, the risk of which is greater with ICI combination therapy than with monotherapy, as reported in a recent study.

Immune checkpoint inhibitors carry some risk of hepatotoxicity

25 Jan 2023

Lidocaine cream helps relieve vax pain in infants

25 Jan 2023

Use of lidocaine 4% cream reduces total cry duration after vaccinations of infants relative to placebo, as shown in a study, noting that both caregivers and nurses are willing to use this cream for pain management in a clinic setting if available.

Lidocaine cream helps relieve vax pain in infants

25 Jan 2023

Insulin injections plus GLP-1 RAs may improve A1c, reduce insulin dose in diabetic patients

25 Jan 2023

Use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) in combination with multiple daily insulin injections (MDII) is associated with an improvement in A1c and a reduction in insulin doses without increased hypoglycaemia, reports a study.

Insulin injections plus GLP-1 RAs may improve A1c, reduce insulin dose in diabetic patients

25 Jan 2023

News & Updates

Showing Pharmacy articles

Showing

Specialty:

SAVE-MORE subgroup analysis further reinforces anakinra benefit in COVID-19

SAVE-MORE subgroup analysis further reinforces anakinra benefit in COVID-19

Proton therapy reirradiation confers survival benefits in head and neck cancer, with caveat

Proton therapy reirradiation confers survival benefits in head and neck cancer, with caveat

Oral ritlecitinib safe, effective for treatment of active nonsegmental vitiligo

Oral ritlecitinib safe, effective for treatment of active nonsegmental vitiligo

Add-on cannabidiol induces sustained seizure reduction in treatment-resistant epilepsy

Add-on cannabidiol induces sustained seizure reduction in treatment-resistant epilepsy

SGLT2 inhibitors cut obstructive airway disease risk in type 2 diabetes

SGLT2 inhibitors cut obstructive airway disease risk in type 2 diabetes

Durable benefits with beti-cel therapy in beta-thalassaemia

Durable benefits with beti-cel therapy in beta-thalassaemia

Low BMD, fracture risk upped in childhood cancer survivors

Low BMD, fracture risk upped in childhood cancer survivors

Immune checkpoint inhibitors carry some risk of hepatotoxicity

Immune checkpoint inhibitors carry some risk of hepatotoxicity

Lidocaine cream helps relieve vax pain in infants

Lidocaine cream helps relieve vax pain in infants

Insulin injections plus GLP-1 RAs may improve A1c, reduce insulin dose in diabetic patients

Insulin injections plus GLP-1 RAs may improve A1c, reduce insulin dose in diabetic patients